Athena Countouriotis Insider Trading $PASG Passage BIO, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).

Athena Countouriotis in Passage BIO, Inc.

Trading Symbol: PASG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: Director
Holdings: 18,900 shares
Latest Transaction: Mar 25 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Athena Countouriotis in Passage BIO, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 25 2020	PASG	Passage BIO, Inc.	Countouriotis Athena	Director	Buy	P	14.98	10,000	149,750	18,900	8.9 K to 18.9 K (+112.36 %)
Mar 25 2020	PASG	Passage BIO, Inc.	Countouriotis Athena	Director	Buy	P	14.98	10,000	149,750	18,900	8.9 K to 18.9 K (+112.36 %)
Mar 02 2020	PASG	Passage BIO, Inc.	Countouriotis Athena	Director	Option Exercise	A	18.00	33,836	609,048	33,836

Page: 1